hydroxyindoleacetic acid has been researched along with epirubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
du Bois, A; Holy, R; Kriesinger-Schröder, H; Vach, W | 1 |
1 trial(s) available for hydroxyindoleacetic acid and epirubicin
Article | Year |
---|---|
5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Hydroxyindoleacetic Acid; Incidence; Middle Aged; Ondansetron; Selective Serotonin Reuptake Inhibitors; Vomiting | 1996 |